Reporter Staff
| This email address is being protected from spambots. You need JavaScript enabled to view it.
July 16, 2024
Research Volunteers Needed
What is the study?
This study aims to characterize social cognition and motivation in HIV and to determine the effect of social cognition and motivation on quality of life in HIV.
Are you eligible?
How many visits?
Pre-Screening interview (2 hours)
Behavioral Testing Sessions (6 hours)
MRI Scans (4 hours)
$25 per hour up to $312.50
Interested?
Contact us: 205.934.8203 NLSB.uab@gmail.com
This study aims to characterize social cognition and motivation in HIV and to determine the effect of social cognition and motivation on quality of life in HIV.
Are you eligible?
- Older than 40 years
- No Neurological Deficits
- No History of Psychotic Symptoms
- No diagnosis of a mood disorder
- No Diagnosis of HIV
- English Speaking
How many visits?
Pre-Screening interview (2 hours)
Behavioral Testing Sessions (6 hours)
MRI Scans (4 hours)
$25 per hour up to $312.50
Interested?
Contact us: 205.934.8203 NLSB.uab@gmail.com
Published in
Clinical Trials
Study Information:
- Are you 18-60 years of age living with HIV, and want to be a part of a vaccine study?
- Is your viral load suppressed/undetectable?
- Are you able to receive a vaccine?
- Are you generally healthy?
- Are you willing to temporarily stop taking antiretrovirals?
You may qualify for a study looking at testing an experimental HIV vaccine with an experimental adjuvant to see how the immune responses change among participants who do an antiretroviral analytical treatment interruption (ATI) compared to those who do not. Compensation at each study visit will be provided for time and travel. Transportation services are also available upon request. If interested, please email sspaulding@uabmc.edu.
Published in
Clinical Trials
July 11, 2024
Unlock the power of effective email communication
Learn 5 steps to writing emails that work in this 30-minute session at 11 a.m. July 15. Register now.
Published in
Learning & Development
July 01, 2024
UAB and Birmingham Promise: a partnership for the future
Through an internship with UAB HR Talent Acquisition, Birmingham City Schools student Jaykease Rosales gained skills and experience and proved to be a strong asset to UAB’s employee recruitment and retention efforts.
Published in
UAB in the Community
June 27, 2024
Annual performance evaluation cycle opens July 1
Eligible employees in Workgroup A will complete self-evaluations in the UAB Perform App and faculty evaluations will be uploaded into the app. Managers must have conversations with employees and complete evaluations by Sept. 30.
Published in
Benefits & Policies
The new initiative from UAB Employee Wellness encourages Blazers to stay active by visiting local green spaces in July and August 2024. Participants who visit three or more by the end of August will be entered to win one of three prize baskets.
Published in
Be Healthy
• Are you 18-70 years of age living with HIV, and want to be a part of a curative study?
• Is your viral load suppressed/undetectable?
• Are you able to receive an infusion or injection?
• Are you generally healthy?
• Are you willing to temporarily stop taking antiretrovirals?
You may qualify for a HIV treatment study looking at an investigational way to effectively clear the HIV virus in areas of the body that standard antiretroviral treatment is unable to reach. You will receive one of two potential intervention methods. One intervention method is a broadly neutralizing antibody that is given to control growth of the HIV virus and to increase the body’s immune system response. The second intervention method is an injection (IL-15 Superagonist) designed to awaken the immune system, activate any dormant HIV virus, and then kill the virus. The duration of this study is approximately 84-112 weeks pending on which intervention method you receive. There is compensation at each study visit for time and travel.
Contact: If interested, please email kspraggins@uabmc.edu or call 205-934-9346
• Is your viral load suppressed/undetectable?
• Are you able to receive an infusion or injection?
• Are you generally healthy?
• Are you willing to temporarily stop taking antiretrovirals?
You may qualify for a HIV treatment study looking at an investigational way to effectively clear the HIV virus in areas of the body that standard antiretroviral treatment is unable to reach. You will receive one of two potential intervention methods. One intervention method is a broadly neutralizing antibody that is given to control growth of the HIV virus and to increase the body’s immune system response. The second intervention method is an injection (IL-15 Superagonist) designed to awaken the immune system, activate any dormant HIV virus, and then kill the virus. The duration of this study is approximately 84-112 weeks pending on which intervention method you receive. There is compensation at each study visit for time and travel.
Contact: If interested, please email kspraggins@uabmc.edu or call 205-934-9346
Published in
Clinical Trials
June 13, 2024
3 chosen as UAB VIPs for second-quarter 2024
John Huffstutler, Nancy Parsons and Angel Simmons are the second-quarter 2024 honorees of the UAB Values in Action Program. Nominations for third-quarter 2024 honorees are open through July 11.
Published in
Awards & Honors
June 06, 2024
Updated training on fiscal responsibility to be required
“Understanding Your UAB Fiscal Responsibility,” which is focused on the role employees play in managing UAB’s financial resources, will be assigned to certain employees based on job function through the UAB Learning System beginning July 1, 2024.
Published in
Learning & Development
The UA System Board of Trustees awarded the rank of Distinguished Professor to Robert Brunner, Yogesh Dwivedi, Helen Krontiras, Cora Elizabeth Lewis, David M. Morris and Michele H. Nichols and the rank of University Professor to Marie Bakitas, Mirjam-Colette Kempf, Verna Keith, Michael Neiderweis and David Vance during its meeting in April 2024.
Published in
Awards & Honors
